Oncolytic cancer therapy with a vaccinia virus strain
Gemcitabine combined with an engineered oncolytic vaccinia virus exhibits a synergistic suppressive effect on the tumor growth of pancreatic cancer
Vaccinia virus-mediated expression of wild-type p53 suppresses glioma cell growth and induces apoptosis.
Adeno-associated virus-mediated survivin mutant Thr34Ala cooperates with oxaliplatin to inhibit tumor growth and angiogenesis in colon cancer
Cdc6 expression as a marker of proliferative activity in brain tumors